Authors:
Olapade-Olaopa, E
Ogunbiyi, JO
MacKay, EH
Muronda, CA
Alonge, TO
Danso, AP
Moscatello, DK
Sandhu, DPS
Shittu, OB
Terry, TR
Wong, AJ
Habib, FK
Citation: E. Olapade-olaopa et al., Further characterization of storage-related alterations in immunoreactivity of archival tissue sections and its implications for collaborative multicenter immunohistochemical studies, APPL IMMUNO, 9(3), 2001, pp. 261-266
Authors:
Collins, AT
Habib, FK
Maitland, NJ
Neal, DE
Citation: At. Collins et al., Identification and isolation of human prostate epithelial stem cells basedon alpha(2)beta(1)-integrin expression, J CELL SCI, 114(21), 2001, pp. 3865-3872
Citation: Cw. Bayne et al., The selectivity and specificity of the actions of the lipido-sterolic extract of serenoa repens (Permixon (R)) on the prostate, J UROL, 164(3), 2000, pp. 876-881
Authors:
Olapade-Olaopa, EO
Moscatello, DK
MacKay, EH
Horsburgh, T
Sandhu, DPS
Terry, TR
Wong, AJ
Habib, FK
Citation: Eo. Olapade-olaopa et al., Evidence for the differential expression of a variant EGF receptor proteinin human prostate cancer, BR J CANC, 82(1), 2000, pp. 186-194
Authors:
Olapade-Alaopa, EO
MacKay, EH
Taub, NA
Sandhu, DPS
Terry, TR
Habib, FK
Citation: Eo. Olapade-alaopa et al., Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stromal, CLIN CANC R, 5(3), 1999, pp. 569-576
Citation: Fk. Habib et al., Factors controlling the expression of 5 alpha-reductase in human prostate:A possible new approach for the treatment of prostate cancer, EUR UROL, 35(5-6), 1999, pp. 439-442
Citation: Cw. Bayne et al., Serenoa repens (Permixon (R)): A 5 alpha-reductase types I and II inhibitor - New evidence in a coculture model of BPH, PROSTATE, 40(4), 1999, pp. 232-241